Indeed, based on these postulates, low adiponectin levels characterising women with obesity and GDM would remove the inhibition of this adipokine on placental insulin signalling and amino acid transport, thereby promoting increased foetal growth [133] (Figure 6). This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.